Disease progression among patients who receive available bladder preservation therapies after failure of BCG therapy in the SEER-Medicare data. Proposal of a new subcategory of the pT3 classification: ...

Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma. Impact of tumor burden on treatment patterns and outcomes in patients with locally advanced or metastatic ...